News
Experts from UMass Medical School said managed care plans can use a variety of tools to combat the opioid crisis, including a therapeutic class management team, according to an article in Pharmacy Practice News.
UMass Medical School’s TrendFinder LTSS data analytics platform helps state agencies and private health plans meet growing demand for home care and other long-term services and supports amid lean budgets.
UMass Medical School’s long-term services and supports (LTSS) solutions will be both celebrated and presented at the National Home and Community Based Services (HCBS) Conference in Baltimore, Maryland, Aug. 27-31.
Utilizing evidence-based practices, being able to constantly monitor the latest research and being nimble are the key components of a successful opioid management program, says Tyson Thompson, PharmD.
UMass Medical School experts will present on increasing third party liability savings in Medicaid programs and standardizing the procurement process at the annual Medicaid Enterprise Systems Conference on August 15-18.
The University of Massachusetts Medical School’s Commonwealth Medicine division (UMass) is pleased to announce its strategic partnership with Long Term Care Innovation, Inc. (LTCI) based in Burlington, Vermont.
Medication assisted treatment has proven to be powerful weapon in communities across the country in efforts to stem the tide of the opioid epidemic. Now, UMass Medical School’s Warren J. Ferguson, MD, is studying how jails and prisons can implement that model, according to a report by STAT.
UMass Medical School experts will present the historical evolution of services and supports for people with disabilities that led to the development of a Preadmission Screening Resident Review (PASRR) during a keynote on the first day of the 2017 PASRR Services in Texas Conference Aug. 9-10.
UMass Medical School will highlight the capabilities of its TrendFinder LTSS data analytics platform at the Mediware conference August 7-9 in New Orleans.
To ensure the right decision is made for individuals going through a disability determination, benefits agencies and organizations should utilize medical professionals and specialists to achieve well-informed conclusions, according to a UMass Medical School disability evaluation expert.
Hepatitis C is one of the top public health challenges facing the U.S., with as many as three to four million people currently living with this “chronic infection,” notes Pavel Lavitas, PharmD, BCPS, of UMass Medical School.
Access to a wide variety of professionals in different specialties is imperative for independent disability reviewers when making a determination, according to the disability determinations medical director at UMass Medical School.
How UMass Medical School is helping MassHealth, the Massachusetts Medicaid program, promote more rational use of opioids is highlighted in a Specialty Pharmacy Continuum article on managed care efforts to address the nationwide addiction crisis.
Pairing patients up with the right medications, sending refill reminders and tracking results are all ingredients for a successful hepatitis C medication management program, says UMass Medical School pharmacy expert.
Amid a nationwide opioid addiction crisis, payers must look well beyond simply containing costs and work closely with doctors who are prescribing these powerful pain medications, says Tyson Thompson, PharmD, a clinical consultant pharmacist at UMass Medical School.
